Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Upfront Carfilzomib, Lenalidomide, Dexamethasone with Transplant in Multiple Myeloma Patients, the IFM KRd final results

Clinical Trials & Observations

Murielle Roussel, Valerie Lauwers-Cances, Soraya Wuilleme, Karim Belhadj, Salomon Manier, Laurent Garderet, Martine Escoffre-Barbe, Slara Mariette, Lotfi Benboubker, Denis Caillot, Cécile Sonntag, Cyrille Touzeau, Jehan Dupuis, Philippe Moreau, Xavier Leleu, Thierry Facon, Benjamin Hébraud, Jill Corre, Michel Attal

Blood blood.2021010744.

DOI: https://doi.org/10.1182/blood.2021010744

Published: 2021

Journal Articles

Comparison of the Performance of Surface Alone or Surface Plus Cytoplasmic Approaches for the Assessment of Minimal Residual Disease in Multiparameter Flow Cytometry in Multiple Myeloma

Marie C Bene, PharmD,DPhil, Nelly Robillard, PhD, Philippe Moreau, MD, Soraya Wuilleme, PharmD, PhD

Blood (2019) 134 (Supplement_1): 1799.

DOI: https://doi.org/10.1182/blood-2019-130607

Published: 2019

Journal Articles

Multicentric Real Life Evaluation of the Impact of Next-Generation Sequencing on the Clinical Management of Chronic Myeloid Malignancies

Blood (2019) 134 (Supplement_1): 5771.

DOI: https://doi.org/10.1182/blood-2019-122958

Published: 2019

Journal Articles

Prognostic Value of Lymphopenia and Lymphocytosis after Peripheral Blood Haplo-Identical Stem Cell Transplantation

Yannick LE Bris, PharmD, Thierry Guillaume, MD PhD, Camille Debord, PharmD, Pierre Peterlin, Soraya Wuilleme, PharmD, PhD, Céline Bressollette, MD PhD, Amandine Le Bourgeois, MD, Alice Garnier, MD, Aurélie Fantou, PharmD, Marie Audrain, MD PhD, Audrey Ménard, Nelly Robillard, PhD, Marion Eveillard, Steven Le Gouill, Berthe Marie Imbert, PharmD, PhD, Marie C Bene, PharmSciD, PhD, Patrice Chevallier, MD

Blood (2019) 134 (Supplement_1): 3319.

DOI: https://doi.org/10.1182/blood-2019-122093

Published: 2019

Journal Articles

A New Cytokine-Based Stratification Is Highly Predictive of Survivals in AML Patients

Blood (2019) 134 (Supplement_1): 1412.

DOI: https://doi.org/10.1182/blood-2019-125774

Published: 2019

Journal Articles

Profound Lymphopenia at the Time of ATG Administration Is Not Predictive of Survivals after Allotransplant Using Purine Analogue/Busulfan-Based Conditioning Regimen

Blood (2019) 134 (Supplement_1): 1985.

DOI: https://doi.org/10.1182/blood-2019-122013

Published: 2019

Journal Articles

Fms-like Tyrosine Kinase 3 Ligand Concentration Kinetic Profile during Induction Is Strongly Predictive of Survivals in AML: Results of the FLAM/Flal Study

Blood (2018) 132 (Supplement 1): 1484.

DOI: https://doi.org/10.1182/blood-2018-99-111694

Published: 2018

Journal Articles

CD38 Expression in B-Lineage Acute Lymphoblastic Leukemia, a Possible Target for Immunotherapy

Marion Eveillard, PharmD, PhD, Victor Floc'h, Nelly Robillard, PhD, Camille Debord, Soraya Wuilleme, PharmD, PhD, Richard Garand, Fanny Rialland, MD, Caroline Thomas, Pierre Peterlin, MD, Thierry Guillaume, MD PhD, Philippe Moreau, Patrice Chevallier, MD PhD, Marie C Bene, PharmSciD, PhD

Blood (2016) 128 (22): 5268.

DOI: https://doi.org/10.1182/blood.V128.22.5268.5268

Published: 2016

Journal Articles

Expansion of T or B Lymphocytes after Unrelated Cord Blood (UCB) Allogeneic Stem Cell Transplantation in Adults Correlates with CMV Reactivation and Is Associated with a Better Outcome

Yannick Le Bris, PharmD, Thierry Guillaume, MD PhD, Marina Iliaquer, PharmD, Jerome Martin, PharmD, PhD, Pierre Peterlin, MD, Audrey Menard, Marion Eveillard, PharmD, Soraya Wuilleme, PharmD, PhD, Nelly Robillard, PhD, Jacques Delaunay, MD, Mohamad Mohty, MD PhD, Alice Garnier, MD, Philippe Moreau, MD PhD, Marie C Bene, PharmSciD, PhD, Patrice Chevallier, MD PhD

Blood (2015) 126 (23): 1947.

DOI: https://doi.org/10.1182/blood.V126.23.1947.1947

Published: 2015

Journal Articles

Misleading acute promyelocytic leukemia morphology

Soraya Wuillème, Yannick Le Bris

Blood (2015) 125 (24): 3815.

DOI: https://doi.org/10.1182/blood-2015-02-616904

Published: 2015

Journal Articles

Relative Stability Of Plasma Cells Immunophenotype In Multiple Myeloma Over Time

Benoit Tessoulin, Steven Legouill, MD PhD, Marion Eveillard, Nelly Robillard, Soraya Wuilleme, Thomas Gastinne, MD, Cyrille Touzeau, MD, Catherine Pellat-Deceunynck, PhD, Marie C Bene, PharmSciD, PhD, Philippe Moreau, MD

Blood (2013) 122 (21): 1885.

DOI: https://doi.org/10.1182/blood.V122.21.1885.1885

Published: 2013

Journal Articles

Paired Immunophenotype Comparison Of Diagnosis and Relapse Samples In B-Lineage Acute Lymphoblastic Leukemia

Marion Eveillard, Richard Garand, MD, Nelly Robillard, Soraya Wuilleme, MD, PhD, Caroline Thomas, M.D., Marion Strullu, Fanny Rialland, M.D., Jacques Delaunay, MD, Patrice Chevallier, MD, PhD, Philippe Moreau, MD, Nicolas Blin, Marie-Christine Bene, PharmSciD, PhD

Blood (2013) 122 (21): 4954.

DOI: https://doi.org/10.1182/blood.V122.21.4954.4954

Published: 2013

Journal Articles

Cereblon (CRBN) Splicing Could Influence Response To IMiDs : A New PCR Strategy to Easily Detect and Semi-Quantify Loss Of The IMiDs Binding Domain

Blood (2013) 122 (21): 3107.

DOI: https://doi.org/10.1182/blood.V122.21.3107.3107

Published: 2013

Journal Articles

Backtracking Subclonal Mutations Of TP53 In Myelodysplasia (MDS) With Del(5q) With Next-Generation Sequencing (NGS)

Blood (2013) 122 (21): 520.

DOI: https://doi.org/10.1182/blood.V122.21.520.520

Published: 2013

Journal Articles

Evaluation of the Intra-LABORATORY Reproducibility of Percentage of Blast Counting In MYELODYSPLASIA

Soraya Wuilleme, MD, PhD, Marion Eveillard, Sophie Barillet, Françoise Accard, Hervé Avet-Loiseau, MD, PhD, Jacques Delaunay, MD, Richard Garand

Blood (2011) 118 (21): 4901.

DOI: https://doi.org/10.1182/blood.V118.21.4901.4901

Published: 2011

Journal Articles

Bortezomib, Lenalidomide, and Dexamethasone (VRD) Consolidation and Lenalidomide Maintenance in Frontline Multiple Myeloma Patients: Updated Results of the IFM 2008 Phase II VRD Intensive Program

Murielle Roussel, Nelly Robillard, Philippe Moreau, MD, Lotfi Benboubker, MD, PhD, Cyrille Hulin, MD, Gerald Marit, MD, PhD, Xavier Leleu, MD, PhD, Brigitte Pegourie, MD, Christophe Fruchart, MD, Denis Caillot, MD, Anne-Marie Stoppa, MD, Thierry Facon, MD, Soraya Wuilleme, MD, PhD, Hervé Avet-Loiseau, MD, PhD, Michel Attal, MD

Blood (2011) 118 (21): 1872.

DOI: https://doi.org/10.1182/blood.V118.21.1872.1872

Published: 2011

Journal Articles

A Single-Tube Seven-Colour Flow Cytometry Assay for Detection of Minimal Residual Disease In Myeloma.

Soraya Wuilleme, Nelly Robillard, MD, Steven Richebourg, Marion Eveillard, Laurence Lodé, Hervé Avet-Loiseau

Blood (2010) 116 (21): 1688.

DOI: https://doi.org/10.1182/blood.V116.21.1688.1688

Published: 2010

Journal Articles

Rational for the Use of a Targeted-Therapy Using ABT-737 In Mantle-Cell Lymphoma

Cyrille Touzeau, Christelle Dousset, Lynda Bodet, Stephanie Bonnaud, Patricia Gomez-Bougie, Thomas Gastinne, Soraya Wuilleme, Anne Moreau, Philippe Moreau, Catherine Pellat-Deceunynck, PhD, Martine Amiot, Steven Le Gouill

Blood (2010) 116 (21): 770.

DOI: https://doi.org/10.1182/blood.V116.21.770.770

Published: 2010

Journal Articles

EVALUATION of the Intra-LABORATORY Reproducibility of Percentage of Blast Counting IN MYELODYSPLASIA

Soraya Wuilleme, PhD, Marion Eveillard, PhD, Sophie Barille, PhD, Francoise Accard, PhD, Laurence Lodé, PhD, Hervé Avet-Loiseau, Richard Garrand, PhD

Blood (2010) 116 (21): 4981.

DOI: https://doi.org/10.1182/blood.V116.21.4981.4981

Published: 2010

Journal Articles

IgG-Secreting B-Cell Lymphoplasmocytoid Leukaemia : Molecular Characterization of Igh Rearrangements.

Laurence Lode, Surinder S. Sahota, PhD, Soraya Wuilleme, Steven Richebourg, Marion Eveillard, Regis Bataille, Herve Avet Loiseau, MD, PhD, Richard Garand, MD

Blood (2008) 112 (11): 1778.

DOI: https://doi.org/10.1182/blood.V112.11.1778.1778

Published: 2008

NARROW

Upfront Carfilzomib, Lenalidomide, Dexamethasone with Transplant in Multiple Myeloma Patients, the IFM KRd final results

Comparison of the Performance of Surface Alone or Surface Plus Cytoplasmic Approaches for the Assessment of Minimal Residual Disease in Multiparameter Flow Cytometry in Multiple Myeloma

Multicentric Real Life Evaluation of the Impact of Next-Generation Sequencing on the Clinical Management of Chronic Myeloid Malignancies

Prognostic Value of Lymphopenia and Lymphocytosis after Peripheral Blood Haplo-Identical Stem Cell Transplantation

A New Cytokine-Based Stratification Is Highly Predictive of Survivals in AML Patients

Profound Lymphopenia at the Time of ATG Administration Is Not Predictive of Survivals after Allotransplant Using Purine Analogue/Busulfan-Based Conditioning Regimen

Fms-like Tyrosine Kinase 3 Ligand Concentration Kinetic Profile during Induction Is Strongly Predictive of Survivals in AML: Results of the FLAM/Flal Study

CD38 Expression in B-Lineage Acute Lymphoblastic Leukemia, a Possible Target for Immunotherapy

Expansion of T or B Lymphocytes after Unrelated Cord Blood (UCB) Allogeneic Stem Cell Transplantation in Adults Correlates with CMV Reactivation and Is Associated with a Better Outcome

Misleading acute promyelocytic leukemia morphology

Relative Stability Of Plasma Cells Immunophenotype In Multiple Myeloma Over Time

Paired Immunophenotype Comparison Of Diagnosis and Relapse Samples In B-Lineage Acute Lymphoblastic Leukemia

Cereblon (CRBN) Splicing Could Influence Response To IMiDs : A New PCR Strategy to Easily Detect and Semi-Quantify Loss Of The IMiDs Binding Domain

Backtracking Subclonal Mutations Of TP53 In Myelodysplasia (MDS) With Del(5q) With Next-Generation Sequencing (NGS)

Evaluation of the Intra-LABORATORY Reproducibility of Percentage of Blast Counting In MYELODYSPLASIA

Bortezomib, Lenalidomide, and Dexamethasone (VRD) Consolidation and Lenalidomide Maintenance in Frontline Multiple Myeloma Patients: Updated Results of the IFM 2008 Phase II VRD Intensive Program

A Single-Tube Seven-Colour Flow Cytometry Assay for Detection of Minimal Residual Disease In Myeloma.

Rational for the Use of a Targeted-Therapy Using ABT-737 In Mantle-Cell Lymphoma

EVALUATION of the Intra-LABORATORY Reproducibility of Percentage of Blast Counting IN MYELODYSPLASIA

IgG-Secreting B-Cell Lymphoplasmocytoid Leukaemia : Molecular Characterization of Igh Rearrangements.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only